Cargando…
HIV-1 integration sites in CD4(+) T cells during primary, chronic, and late presentation of HIV-1 infection
HIV-1 is capable of integrating its genome into that of its host cell. We examined the influence of the activation state of CD4(+) T cells, the effect of antiretroviral therapy (ART), and the clinical stage of HIV-1 infection on HIV-1 integration site features and selection. HIV-1 integration sites...
Autores principales: | Kok, Yik Lim, Vongrad, Valentina, Chaudron, Sandra E., Shilaih, Mohaned, Leemann, Christine, Neumann, Kathrin, Kusejko, Katharina, Di Giallonardo, Francesca, Kuster, Herbert, Braun, Dominique L., Kouyos, Roger D., Günthard, Huldrych F., Metzner, Karin J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Clinical Investigation
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8262285/ https://www.ncbi.nlm.nih.gov/pubmed/33784259 http://dx.doi.org/10.1172/jci.insight.143940 |
Ejemplares similares
-
Monocyte-derived macrophages exhibit distinct and more restricted HIV-1 integration site repertoire than CD4(+) T cells
por: Kok, Yik Lim, et al.
Publicado: (2016) -
Spontaneous reactivation of latent HIV-1 promoters is linked to the cell cycle as revealed by a genetic-insulators-containing dual-fluorescence HIV-1-based vector
por: Kok, Yik Lim, et al.
Publicado: (2018) -
A Novel High Throughput, Parallel Infection Assay for Determining the Replication Capacities of 346 Primary HIV-1 Isolates of the Zurich Primary HIV-1 Infection Study in Primary Cells
por: Rindler, Audrey E., et al.
Publicado: (2021) -
Absence of Proviral Human Immunodeficiency Virus (HIV) Type 1 Evolution in Early-Treated Individuals With HIV Switching to Dolutegravir Monotherapy During 48 Weeks
por: Jörimann, Lisa, et al.
Publicado: (2023) -
Reappearance of Minority K103N HIV-1 Variants after Interruption of ART Initiated during Primary HIV-1 Infection
por: Metzner, Karin J., et al.
Publicado: (2011)